@article {Cohen2020.06.12.20129221, author = {Robert Cohen and Camille Jung and Naim Ouldali and Aur{\'e}lie Sellam and Christophe Batard and Fabienne Cahn-Sellem and Annie Elbez and Alain Wollner and Olivier Romain and Fran{\c c}ois Corrard and Said Aberrane and Nathalie Soismier and Rita Creidy and Mounira Smati-Lafarge and Odile Launay and St{\'e}phane B{\'e}chet and Emmanuelle Varon and Corinne Levy}, title = {Assessment of spread of SARS-CoV-2 by RT-PCR and concomitant serology in children in a region heavily affected by COVID-19 pandemic}, elocation-id = {2020.06.12.20129221}, year = {2020}, doi = {10.1101/2020.06.12.20129221}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {Background Several studies indicated that children seem to be less frequently infected with SARS-CoV-2 and potentially less contagious. To examine the spread of SARS-CoV-2 we combined both RT-PCR testing and serology in children in the most affected region in France, during the COVID-19 epidemic.Methods From April 14, 2020 to May 12, 2020, we conducted a cross-sectional prospective, multicenter study. Healthy controls and pauci-symptomatic children from birth to age 15 years were enrolled by 27 ambulatory pediatricians. A nasopharyngeal swab was taken for detection of SARS-CoV-2 by RT-PCR and a microsample of blood for micro-method serology.Results Among the 605 children, 322 (53.2\%) were asymptomatic and 283 (46.8\%) symptomatic. RT-PCR testing and serology were positive for 11 (1.8\%) and 65 (10.7\%) of all children, respectively. Only 3 children were RT-PCR{\textendash}positive without any antibody response have been detected. The frequency of positivity on RT-PCR for SARS-CoV-2 was significantly higher in children with positive serology than those with a negative one (12.3\% vs 0.6\%, p\<0.001). Contact with a person with proven COVID-19 increased the odds of positivity on RT-PCR (OR 7.8, 95\% confidence interval [1.5; 40.7]) and serology (15.1 [6.6;34.6]).Conclusion In area heavily affected by COVID-19, after the peak of the first epidemic wave and during the lockdown, the rate of children with positive SARS-CoV-2 RT-PCR was very low (1.8\%), but the rate of positive on serology was higher (10.7\%). Most of PCR positive children had at the same time positive serology.What is already known on this topic?- As compared with adults, children seem to be less frequently infected with SARS-CoV-2 and potentially less contagious according to several studies.- Most of the studies were based on RT-PCR SARS-CoV-2 testing, without antibody assays.What this study adds?- This study combining RT-PCR and serologic testing, assessed the spread of SARS-CoV-2 infection in children in area heavily affected by COVID-19 pandemic.- Among a large cohort of children (\>600), 11 (1.8\%) were positive on RT-PCR for SARS-CoV-2 and 65 (10.7\%) were positive on serology.- The only factor affecting positivity of RT-PCR for SARS-CoV-2 or serology was the household contact COVID-19.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNCT04318431Funding StatementThis work was supported by the French Ministry of Health DGOS PHRC regional IDF 2020 no. AOR20095.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study protocol was approved by an ethics committee (CPP IDF IX no. 08-022). Parents of all infants provided written informed consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are available upon reasonable request}, URL = {https://www.medrxiv.org/content/early/2020/07/23/2020.06.12.20129221}, eprint = {https://www.medrxiv.org/content/early/2020/07/23/2020.06.12.20129221.full.pdf}, journal = {medRxiv} }